Hypha are delighted to announce the appointment of Lisbet Kvaerno PhD as Head of Synthetic Chemistry at Hypha.
Lisbet has >20 years’ experience in challenging organic synthesis, process chemistry, CMC development and project management within the pharmaceutical industry (H. Lundbeck A/S, Novo Nordisk Pharmatech A/S), biotech start-ups (Lipideon A/G) and multiple academic institutions (Max Planck Institute of Coal Research Germany, ETH Zurich Switzerland, Harvard University USA, Technical University of Denmark). During her 8 years at Lundbeck in Copenhagen, she was promoted to Process Research Senior Specialist, focussing on synthesizing hard-to-access metabolites and bioanalytical standards in low-mg to multiple-gram quantities.
Lisbet joins Hypha to expand our capabilities in providing drug metabolites and derivatives to clients worldwide.
